De novo synthesized gene libraries

US10773232B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10773232-B2
Application numberUS-201916535779-A
CountryUS
Kind codeB2
Filing dateAug 8, 2019
Priority dateAug 5, 2013
Publication dateSep 15, 2020
Grant dateSep 15, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

De novo synthesized large libraries of nucleic acids are provided herein with low error rates. Further, devices for the manufacturing of high-quality building blocks, such as oligonucleotides, are described herein. Longer nucleic acids can be synthesized in parallel using microfluidic assemblies. Further, methods herein allow for the fast construction of large libraries of long, high-quality genes. Devices for the manufacturing of large libraries of long and high-quality nucleic acids are further described herein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for computer-assisted polynucleotide synthesis, comprising: receiving instructions in a computer readable non-transient medium for synthesis of DNA sequences each having a full length sequence of at least 100 bases in length; processing the instructions in a computer and transmitting synthesis instructions to a material deposition device, wherein the instructions provide for synthesis of a plurality of polynucleotides that encode for the DNA sequences; and releasing synthesis reagents from the material deposition device to synthesize the plurality of polynucleotides, wherein 67% or more of the plurality of polynucleotides that are synthesized encode for the full length sequence of the DNA sequences compared to the DNA sequences received in the instructions in the computer readable non-transient medium without purification, and wherein the plurality of polynucleotides comprise a plurality of different nucleotide bases. 2. The method of claim 1 , wherein at least 70% of the plurality of polynucleotides that are synthesized encode for the full length sequence of the DNA sequences compared to the DNA sequences received in the instructions in the computer readable non-transient medium without purification. 3. The method of claim 1 , wherein at least 81% of the plurality of polynucleotides that are synthesized encode for the full length sequence of the DNA sequences compared to the DNA sequences received in the instructions in the computer readable non-transient medium without purification. 4. The method of claim 1 , wherein at least 89% of the plurality of polynucleotides that are synthesized encode for the full length sequence of the DNA sequences compared to the DNA sequences received in the instructions in the computer readable non-transient medium without purification. 5. The method of claim 1 , further comprising performance of size selection to the plurality of polynucleotides, wherein the size selection is based on the DNA sequences received in the instructions in the computer readable non-transient medium. 6. The method of claim 1 , wherein the DNA sequences are cDNA sequences. 7. The method of claim 1 , wherein the plurality of polynucleotides comprises at least 5000 polynucleotides. 8. The method of claim 1 , wherein the plurality of polynucleotides comprises at least 10,000 polynucleotides. 9. The method of claim 1 , wherein the plurality of polynucleotides collectively encode for at least 500 genes. 10. The method of claim 1 , wherein the DNA sequences have a length of 100 to 300 bases. 11. The method of claim 1 , further comprising purification of the plurality of polynucleotides that are synthesized. 12. A method for polynucleotide synthesis, comprising: receiving DNA sequences each having a full length sequence of at least 100 bases in length; and synthesizing a plurality of polynucleotides encoding for the DNA sequences, wherein 67% or more of the plurality of polynucleotides that are synthesized encode for the full length sequence of the DNA sequences without purification, and wherein the plurality of polynucleotides comprise a plurality of different nucleotide bases. 13. The method of claim 12 , wherein the DNA sequences are cDNA sequences. 14. The method of claim 12 , wherein the plurality of polynucleotides comprises at least 5,000 polynucleotides. 15. The method of claim 12 , wherein the plurality of polynucleotides comprises at least 100,000 polynucleotides. 16. The method of claim 12 , wherein the plurality of polynucleotides collectively encode for at least 500 genes. 17. The method of claim 12 , wherein the plurality of polynucleotides collectively encode for at least 10,000 genes. 18. The method of claim 12 , wherein the DNA sequences have a length of 100 to 300 bases. 19. The method of claim 12 , wherein at least 70% of the plurality of polynucleotides that are synthesized encode for the full length sequence of the DNA sequences without purification. 20. The method of claim 12 , wherein at least 81% of the plurality of polynucleotides that are synthesized encode for the full length sequence of the DNA sequences without purification. 21. The method of claim 12 , wherein at least 89% of the plurality of polynucleotides that are synthesized encode for the full length sequence of the DNA sequences without purification. 22. The method of claim 12 , further comprising performance of size selection to the plurality of polynucleotides, wherein the size selection is based on the DNA sequences received. 23. The method of claim 12 , further comprising purification of the plurality of polynucleotides that are synthesized.

Assignees

Inventors

Classifications

  • Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title

  • Immobilisation or binding · CPC title

  • Solid-phase processes · CPC title

  • C40B50/14Primary

    Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support · CPC title

  • General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10773232B2 cover?
De novo synthesized large libraries of nucleic acids are provided herein with low error rates. Further, devices for the manufacturing of high-quality building blocks, such as oligonucleotides, are described herein. Longer nucleic acids can be synthesized in parallel using microfluidic assemblies. Further, methods herein allow for the fast construction of large libraries of long, high-quality ge…
Who is the assignee on this patent?
Twist Bioscience Corp
What technology area does this patent fall under?
Primary CPC classification C40B50/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).